| human | Q5 |
| P496 | ORCID iD | 0000-0001-9646-6208 |
| P69 | educated at | Royal Holloway, University of London | Q1202039 |
| University of Lancaster | Q262854 | ||
| Birkbeck, University of London | Q375606 | ||
| P106 | occupation | researcher | Q1650915 |
| Q88623930 | Acanthamoeba Keratitis: Current Status and Urgent Research Priorities |
| Q38639961 | Acanthamoeba castellanii interactions with Streptococcus pneumoniae and Streptococcus pyogenes. |
| Q46323131 | Animals living in polluted environments are a potential source of anti-tumor molecule(s). |
| Q89523440 | Antiamoebic activity of plant-based natural products and their conjugated silver nanoparticles against Acanthamoeba castellanii (ATCC 50492) |
| Q115658285 | Antibacterial Effects of Derivatives of Porphyrin, Naphthalene diimide, Aminophenol and Benzodioxane on Methicillin Resistant Staphylococcus aureus and Neuropathogenic Escherichia coli K1 |
| Q90633118 | Antibacterial Effects of Quinazolin-4(3H)-One Functionalized-Conjugated Silver Nanoparticles |
| Q91573179 | Antidiabetic Drugs and Their Nanoconjugates Repurposed as Novel Antimicrobial Agents against Acanthamoeba castellanii |
| Q64093008 | Antimicrobial activities of green synthesized gums-stabilized nanoparticles loaded with flavonoids |
| Q90020897 | Antimicrobial discovery from natural and unusual sources |
| Q92796882 | Aryl Quinazolinone Derivatives as Novel Therapeutic Agents against Brain-Eating Amoebae |
| Q35209525 | Atomic force microscopic imaging of Acanthamoeba castellanii and Balamuthia mandrillaris trophozoites and cysts |
| Q41467455 | Balamuthia mandrillaris: Morphology, biology, and virulence |
| Q93118289 | Biologically active metabolite(s) from haemolymph of red-headed centipede Scolopendra subspinipes possess broad spectrum antibacterial activity |
| Q38803807 | Biology and pathogenesis of Naegleria fowleri |
| Q42224262 | Black cobra (Naja naja karachiensis) lysates exhibit broad-spectrum antimicrobial activities |
| Q39238919 | Brain-Eating Amoebae: Predilection Sites in the Brain and Disease Outcome |
| Q47932685 | Brain-Eating Amoebae: Silver Nanoparticle Conjugation Enhanced Efficacy of Anti-Amoebic Drugs against Naegleria fowleri |
| Q92349998 | Brain-eating Amoebae Infection: Challenges and Opportunities in Chemotherapy |
| Q28651985 | Cellulose degradation: a therapeutic strategy in the improved treatment of Acanthamoeba infections |
| Q94653952 | Centralized air-conditioning and transmission of novel coronavirus |
| Q64969114 | Cobalt nanoparticles as novel nanotherapeutics against Acanthamoeba castellanii. |
| Q63246683 | Cockroaches, locusts, and envenomating arthropods: a promising source of antimicrobials |
| Q47216509 | Combating Acanthamoeba spp. cysts: what are the options? |
| Q46305987 | Crocodiles and alligators: Antiamoebic and antitumor compounds of crocodiles |
| Q91724560 | Crocodiles and alligators: physicians' answer to cancer? |
| Q40796845 | Culturable Aerobic and Facultative Anaerobic Intestinal Bacterial Flora of Black Cobra (Naja naja karachiensis) in Southern Pakistan |
| Q98569532 | Current strategies to treat Acanthamoeba keratitis: a patent overview |
| Q98569531 | Current treatment options of Balamuthia mandrillaris: a patent overview |
| Q64326997 | Cytotoxic effects of Benzodioxane, Naphthalene diimide, Porphyrin and Acetamol derivatives on HeLa cells |
| Q54231808 | Development of nanoparticle-assisted PCR assay in the rapid detection of brain-eating amoebae. |
| Q91445939 | Effects of Shape and Size of Cobalt Phosphate Nanoparticles against Acanthamoeba castellanii |
| Q47937479 | Future Priorities in Tackling Infections Due to Brain-Eating Amoebae. |
| Q92203551 | Galactose as novel target against Acanthamoeba cysts |
| Q89391695 | Gold Nanoparticle-Conjugated Cinnamic Acid Exhibits Antiacanthamoebic and Antibacterial Properties |
| Q92980066 | Gold Nanoparticles Conjugation Enhances Antiacanthamoebic Properties of Nystatin, Fluconazole and Amphotericin B |
| Q111319857 | Gut Bacteria of Rattus rattus (Rat) Produce Broad-Spectrum Antibacterial Lipopeptides |
| Q90284373 | Gut Bacteria of Water Monitor Lizard (Varanus salvator) Are a Potential Source of Antibacterial Compound(s) |
| Q91329690 | Gut bacteria of Cuora amboinensis (turtle) produce broad-spectrum antibacterial molecules |
| Q89986438 | Gut bacteria of animals living in polluted environments exhibit broad-spectrum antibacterial activities |
| Q92806704 | Gut bacteria of animals/pests living in polluted environments are a potential source of antibacterials |
| Q49861586 | Gut bacteria of cockroaches are a potential source of antibacterial compound(s). |
| Q40506281 | Identification and characterization of antibacterial compound(s) of cockroaches (Periplaneta americana). |
| Q90434741 | Identification of antibacterial molecule(s) from animals living in polluted environments |
| Q91162099 | Importance of Theranostics in Rare Brain-Eating Amoebae Infections |
| Q52649133 | In vitro inhibition of protease-activated receptors 1, 2 and 4 demonstrates that these receptors are not involved in an Acanthamoeba castellanii keratitis isolate-mediated disruption of the human brain microvascular endothelial cells. |
| Q33360350 | Is there evidence of sexual reproduction (meiosis) in Acanthamoeba? |
| Q35982937 | Isolation of Balamuthia mandrillaris-specific antibody fragments from a bacteriophage antibody display library. |
| Q95929367 | Isoniazid Conjugated Magnetic Nanoparticles Loaded with Amphotericin B as a Potent Antiamoebic Agent against Acanthamoeba castellanii |
| Q90201741 | Leptospirosis: Increasing importance in developing countries |
| Q92122093 | Novel Azoles as Antiparasitic Remedies against Brain-Eating Amoebae |
| Q92640284 | Novel antiacanthamoebic compounds belonging to quinazolinones |
| Q91284204 | Novel insights into the potential role of ion transport in sensory perception in Acanthamoeba |
| Q90867904 | Occurrence and molecular characterisation of Acanthamoeba isolated from recreational hot springs in Malaysia: evidence of pathogenic potential |
| Q91539216 | Occurrence of free-living amoebae (Acanthamoeba, Balamuthia, Naegleria) in water samples in Peninsular Malaysia |
| Q92198853 | Oleic Acid Coated Silver Nanoparticles Showed Better in Vitro Amoebicidal Effects against Naegleria fowleri than Amphotericin B |
| Q92059541 | Oleic acid-conjugated silver nanoparticles as efficient antiamoebic agent against Acanthamoeba castellanii |
| Q39044870 | Pathogenesis of microbial keratitis |
| Q40169089 | Presence of rotavirus and free-living amoebae in the water supplies of Karachi, Pakistan. |
| Q21092270 | Primary amoebic meningoencephalitis caused by Naegleria fowleri: an old enemy presenting new challenges |
| Q90710173 | Repositioning of Guanabenz in Conjugation with Gold and Silver Nanoparticles against Pathogenic Amoebae Acanthamoeba castellanii and Naegleria fowleri |
| Q89774939 | Repurposing of Drugs Is a Viable Approach to Develop Therapeutic Strategies against Central Nervous System Related Pathogenic Amoebae |
| Q90983498 | Sera/Organ Lysates of Selected Animals Living in Polluted Environments Exhibit Cytotoxicity against Cancer Cell Lines |
| Q93178334 | Silver Nanoparticle Conjugation-Enhanced Antibacterial Efficacy of Clinically Approved Drugs Cephradine and Vildagliptin |
| Q47794406 | Silver nanoparticle conjugation affects antiacanthamoebic activities of amphotericin B, nystatin, and fluconazole. |
| Q121336949 | Space medicine: gut microbiome of hardy species is a potential source to counter disorders during space travel |
| Q46305663 | Status of the effectiveness of contact lens disinfectants in Malaysia against keratitis-causing pathogens. |
| Q40093736 | Strategies to counter transmission of "superbugs" by targeting free-living amoebae. |
| Q28081584 | Stress management in cyst-forming free-living protists: programmed cell death and/or encystment |
| Q90211106 | Synthetic Dihydropyridines as Novel Antiacanthamoebic Agents |
| Q40322348 | Targeting Brain-Eating Amoebae Infections. |
| Q38947534 | The Development of Drugs against Acanthamoeba Infections. |
| Q91964640 | The Use of Nanomedicine for Targeted Therapy against Bacterial Infections |
| Q42593529 | The immortal amoeba: a useful model to study cellular differentiation processes? |
| Q100377937 | The increasing importance of the novel coronavirus |
| Q50857094 | The use of dimethyl sulfoxide in contact lens disinfectants is a potential preventative strategy against contracting Acanthamoeba keratitis. |
| Q93002998 | trans-Cinnamic Acid Conjugated Gold Nanoparticles as Potent Therapeutics against Brain-Eating Amoeba Naegleria fowleri |
Search more.